Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Hahn Insider Profile
4 Followers
Mark Hahn, EVP & CFO at Melinta Therapeutics, holds 0.00 shares in Melinta Therapeutics (Ticker: MLNTQ), holds 15.03M shares in Verona Pharma (Ticker: VRNA), holds 0.00 shares in Dova Pharmaceuticals (Ticker: DOVA). Most recently, Mark Hahn ― shares of Melinta Therapeutics on ― for an estimated value of ―.
Mark Hahn Melinta Therapeutics (MLNTQ)EVP & CFO
Melinta Therapeutics (MLNTQ)
EVP & CFO
Not Ranked
Mark Hahn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CFO
Roles that Mark Hahn holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Mark Hahn
Mark Hahn's Trading History
Melinta Therapeutics
―
―
―
$0.00
Dova Pharmaceuticals
Nov 12, 2019
―
Uninformative Sell
―
$0.00
Verona Pharma
Feb 05, 2024
CFO
Uninformative Sell
1.10M
$232.54M
List of latest transactions for each holding click on a transaction to see Mark Hahn's performance on stock
You May Also Like
Mark Hahn insider profile FAQ
What is the percentage of profitable transactions made by Mark Hahn?
The percentage of profitable transactions made by Mark Hahn is ―.
What is the average return per transaction made by Mark Hahn?
The average return per transaction made by Mark Hahn is ―.
What stocks does Mark Hahn hold?
Mark Hahn holds: MLNTQ, DOVA, VRNA stocks.
What was Mark Hahn’s latest transaction?
Mark Hahn latest transaction was an Uninformative Buy of ―.
What was Mark Hahn's most profitable transaction?
Mark Hahn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mark Hahn's role in Melinta Therapeutics?
Mark Hahn's role in Melinta Therapeutics is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.